Abstract: The present invention relates to a composition for preventing, alleviating or treating sarcopenia, containing D-ribo-2-hexulose as an active ingredient. D-ribo-2-hexulose of the present invention is a sweetener capable of replacing sugar, is harmless to the human body and does not cause side effects in normal cells so as to be safe for the human body, inhibits the degradation of myoproteins, and can exhibit muscle strengthening effects by increasing muscle mass, and thus the present invention is expected to be effectively usable in the prevention, alleviation or treatment of sarcopenia.

Abstract: The present invention relates to a composition for preventing or treating lipid-related metabolic diseases. The composition according to the present invention comprises D-psicose as an active ingredient. D-psicose has the ability to inhibit lipid absorption in the small intestine and considerably increase lipid levels in feces. Due to its ability, D-psicose is effective in inhibiting the formation of body fat. In addition, D-psicose reduces body weight, body fat mass, and plasma lipid to normal levels to normalize body weight, body fat mass, and plasma lipid profiles. Due to these advantages, D-psicose is expected to find application in pharmaceutical drugs, health functional foods, and functional foods suitable for preventing and/or treating lipid-related metabolic diseases.